6-Aminoquinazoline - CAS 101421-72-1
Catalog: |
BB000506 |
Product Name: |
6-Aminoquinazoline |
CAS: |
101421-72-1 |
Synonyms: |
6-quinazolinamine; quinazolin-6-amine |
IUPAC Name: | quinazolin-6-amine |
Description: | 6-Aminoquinazoline has an effect on TRPC1-mediated neuronal store-operated Ca entry pathway, which delayed the progression of Huntington's disease motor phenotype in Drosophila, making it a therapeutic target for Huntington's disease treatment. |
Molecular Weight: | 145.16 |
Molecular Formula: | C8H7N3 |
Canonical SMILES: | C1=CC2=NC=NC=C2C=C1N |
InChI: | InChI=1S/C8H7N3/c9-7-1-2-8-6(3-7)4-10-5-11-8/h1-5H,9H2 |
InChI Key: | XFGPXURFKAUHQR-UHFFFAOYSA-N |
Boiling Point: | 335.9 °C at 760 mmHg |
Density: | 1.292 g/cm3 |
MDL: | MFCD10697883 |
LogP: | 1.79320 |
GHS Hazard Statement: | H302+H312+H332 (100%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021202936-A1 | Pyrazolylpropanamide compounds and uses thereof for treatment of prostate cancer | 20200402 |
CN-112538072-A | Novel aminopyrimidine EGFR (epidermal growth factor receptor) inhibitor | 20190921 |
CN-112110918-A | Spiro-substituted pyrimido-cyclic compounds, preparation method and medical application thereof | 20190621 |
WO-2020243373-A1 | Selective androgen receptor degrader (sard) ligands and methods of use thereof | 20190529 |
WO-2020219417-A1 | Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, and/or cxcr4 chemokine receptors | 20190424 |
PMID | Publication Date | Title | Journal |
21510893 | 20110421 | Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells | Journal of neuroinflammation |
21931671 | 20110101 | Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy | PloS one |
21203444 | 20101223 | Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae | PloS one |
16428934 | 20060201 | The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo | Anti-cancer drugs |
15982640 | 20050815 | Mechanism of action of a novel 'combi-triazene' engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency | Biochemical pharmacology |
Complexity: | 137 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.063997236 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.063997236 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 51.8 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS